Those data provide new insights on the role played by WDFY3-AS2 in the tumorigenic process, including TNBC breast tumors, which warranted furthers experimental and clinical studies to better understand the potential role of WDFY3-AS2 as a breast cancer biomarker. This evidence concerns the gene WDFY3 and breast cancer.